Loading Events
  • This event has passed.

Assessing Gaps and Unmet Needs in HPV-Related Disease

June 1, 2020 - June 2, 2020

Human papillomavirus (HPV) has the potential to cause cervical, oropharyngeal, vaginal, vulvar, and anal cancers. Even though the HPV vaccine is safe and effective in preventing cervical cancer, genital warts, and other cancers that affect both women and men, vaccination rates in the U.S. remain surprisingly low among adolescents and young adults. Regular screenings also help decrease the rate of cervical cancer, especially for older women who didn’t have the opportunity to get the vaccine. Currently, there is no treatment for the virus itself, but research is ongoing.

SWHR convened a diverse group of interdisciplinary researchers, clinicians, and patients for a closed-door virtual roundtable meeting on HPV-related disease in women. The experts discussed HPV-related disease in women and the gaps in research, clinical practice, and patient education that need to be filled to improve health outcomes in women with HPV pre-cancer.

Details

Start:
June 1, 2020
End:
June 2, 2020
Event Categories:
, , ,

Organizer

SWHR

Objectives

 

  • Review the state of the science for HPV-related disease in women
  • Identify knowledge gaps in research, clinical practice, and patient education
  • Discuss and provide recommendations on how these gaps can be overcome

Participants

  • J. Michael Berry, MD, Associate Clinical Professor, Department of Medicine, UCSF
  • Tamika Felder, patient advocate, Founder, Cervivor
  • Naomi Jay, NP, PhD, women’s health nurse practitioner, UCSF
  • Michele Longabaugh, RN, patient advocate, Anal Cancer Foundation
  • Janette Merrill, Associate Director of Strategic Initiatives, American Society of Clinical Oncology
  • Jenna B. Messman, PhD, Sexual Health Program Coordinator, University of Maryland Health Center, College Park
  • Sarah Nielsen, PhD, patient advocate, Associate Professor of Human Relations, High Point University
  • Rebecca Perkins, MD, Associate Professor, Obstetrics and Gynecology, Boston University School of Medicine

 

  • Tami Rowen, MD, Assistant Professor, Obstetrics, Gynecology and Gynecologic Surgery, UCSF
  • Mona Saraiya, MD, MPH, Medical Officer and Team Lead, CDC’s Division of Cancer Prevention and Control’s Epidemiology and Applied Research Branch
  • Debbie Saslow, PhD, Senior Director of HPV-Related and Women’s Cancers, American Cancer Society
  • Celina Schocken, Executive Director and Co-Founder, TogetHER
  • Karen Smith-McCune, MD, PhD, former Director, UCSF/Mount Zion Dysplasia Clinic
  • Cornelia Trimble, MD, Professor of Gynecology and Obstetrics, Johns Hopkins Medicine

Sponsor